Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and is Activated by PPARβ/δ Deficiency
Fibroblast growth factor 21 (FGF21), a peptide hormone with pleiotropic effects on carbohydrate and lipid metabolism, is considered a target for the treatment of diabetes. In this study, we investigated the role of Peroxisome Proliferator-Activated Receptor (PPAR)β/δ deficiency in hepatic FGF21 regu...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/83383 http://hdl.handle.net/10220/41419 |
| _version_ | 1824453538561916928 |
|---|---|
| author | Zarei, Mohammad Barroso, Emma Leiva, Rosana Barniol-Xicota, Marta Pujol, Eugènia Escolano, Carmen Vázquez, Santiago Palomer, Xavier Pardo, Virginia González-Rodríguez, Águeda Valverde, Ángela M. Quesada-López, Tania Villarroya, Francesc Wahli, Walter Vázquez-Carrera, Manuel |
| author2 | Lee Kong Chian School of Medicine (LKCMedicine) |
| author_facet | Lee Kong Chian School of Medicine (LKCMedicine) Zarei, Mohammad Barroso, Emma Leiva, Rosana Barniol-Xicota, Marta Pujol, Eugènia Escolano, Carmen Vázquez, Santiago Palomer, Xavier Pardo, Virginia González-Rodríguez, Águeda Valverde, Ángela M. Quesada-López, Tania Villarroya, Francesc Wahli, Walter Vázquez-Carrera, Manuel |
| author_sort | Zarei, Mohammad |
| collection | NTU |
| description | Fibroblast growth factor 21 (FGF21), a peptide hormone with pleiotropic effects on carbohydrate and lipid metabolism, is considered a target for the treatment of diabetes. In this study, we investigated the role of Peroxisome Proliferator-Activated Receptor (PPAR)β/δ deficiency in hepatic FGF21 regulation. Increased Fgf21 expression was observed in liver of PPARβ/δ-null mice and in mouse primary hepatocytes when this receptor was knocked down by small interfering RNA (siRNA). Increased Fgf21 was associated with enhanced protein levels in the heme-regulated eukaryotic translation initiation factor 2α (eIF2α) kinase (HRI). This increase caused enhanced levels of phosphorylated eIF2α and activating transcription factor (ATF) 4, which is essential for Fgf21-induced expression. siRNA analysis demonstrated that HRI regulates Fgf21 expression in primary hepatocytes. Enhanced Fgf21 expression attenuated tunicamycin-induced endoplasmic reticulum stress, as demonstrated by using a neutralizing antibody against FGF21. Interestingly, increased Fgf21 expression in mice fed a HFD or hepatocytes exposed to palmitate was accompanied by reduced PPARβ/δ and activation of the HRI-eIF2α-ATF4 pathway. Moreover, pharmacological activation of HRI increased Fgf21 expression and reduced lipid-induced hepatic steatosis and glucose intolerance and these effects were not observed in Fgf21-null mice. Overall, these findings suggest that HRI is a potential target for regulating hepatic FGF21 levels. |
| first_indexed | 2025-02-19T03:08:01Z |
| format | Journal Article |
| id | ntu-10356/83383 |
| institution | Nanyang Technological University |
| language | English |
| last_indexed | 2025-02-19T03:08:01Z |
| publishDate | 2016 |
| record_format | dspace |
| spelling | ntu-10356/833832020-11-01T05:30:00Z Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and is Activated by PPARβ/δ Deficiency Zarei, Mohammad Barroso, Emma Leiva, Rosana Barniol-Xicota, Marta Pujol, Eugènia Escolano, Carmen Vázquez, Santiago Palomer, Xavier Pardo, Virginia González-Rodríguez, Águeda Valverde, Ángela M. Quesada-López, Tania Villarroya, Francesc Wahli, Walter Vázquez-Carrera, Manuel Lee Kong Chian School of Medicine (LKCMedicine) ATF4 ER stress Fibroblast growth factor 21 (FGF21), a peptide hormone with pleiotropic effects on carbohydrate and lipid metabolism, is considered a target for the treatment of diabetes. In this study, we investigated the role of Peroxisome Proliferator-Activated Receptor (PPAR)β/δ deficiency in hepatic FGF21 regulation. Increased Fgf21 expression was observed in liver of PPARβ/δ-null mice and in mouse primary hepatocytes when this receptor was knocked down by small interfering RNA (siRNA). Increased Fgf21 was associated with enhanced protein levels in the heme-regulated eukaryotic translation initiation factor 2α (eIF2α) kinase (HRI). This increase caused enhanced levels of phosphorylated eIF2α and activating transcription factor (ATF) 4, which is essential for Fgf21-induced expression. siRNA analysis demonstrated that HRI regulates Fgf21 expression in primary hepatocytes. Enhanced Fgf21 expression attenuated tunicamycin-induced endoplasmic reticulum stress, as demonstrated by using a neutralizing antibody against FGF21. Interestingly, increased Fgf21 expression in mice fed a HFD or hepatocytes exposed to palmitate was accompanied by reduced PPARβ/δ and activation of the HRI-eIF2α-ATF4 pathway. Moreover, pharmacological activation of HRI increased Fgf21 expression and reduced lipid-induced hepatic steatosis and glucose intolerance and these effects were not observed in Fgf21-null mice. Overall, these findings suggest that HRI is a potential target for regulating hepatic FGF21 levels. Accepted version 2016-09-06T03:54:22Z 2019-12-06T15:21:16Z 2016-09-06T03:54:22Z 2019-12-06T15:21:16Z 2016 Journal Article Zarei, M., Barroso, E., Leiva, R., Barniol-Xicota, M., Pujol, E., Escolano, C., et al. (2016). Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and is Activated by PPARβ/δ Deficiency. Diabetes, in press. 0012-1797 https://hdl.handle.net/10356/83383 http://hdl.handle.net/10220/41419 10.2337/db16-0155 en Diabetes © 2016 American Diabetes Association. This is the author created version of a work that has been peer reviewed and accepted for publication by Diabetes, American Diabetes Association. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.2337/db16-0155]. 48 p. application/pdf |
| spellingShingle | ATF4 ER stress Zarei, Mohammad Barroso, Emma Leiva, Rosana Barniol-Xicota, Marta Pujol, Eugènia Escolano, Carmen Vázquez, Santiago Palomer, Xavier Pardo, Virginia González-Rodríguez, Águeda Valverde, Ángela M. Quesada-López, Tania Villarroya, Francesc Wahli, Walter Vázquez-Carrera, Manuel Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and is Activated by PPARβ/δ Deficiency |
| title | Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and is Activated by PPARβ/δ Deficiency |
| title_full | Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and is Activated by PPARβ/δ Deficiency |
| title_fullStr | Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and is Activated by PPARβ/δ Deficiency |
| title_full_unstemmed | Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and is Activated by PPARβ/δ Deficiency |
| title_short | Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and is Activated by PPARβ/δ Deficiency |
| title_sort | heme regulated eif2α kinase modulates hepatic fgf21 and is activated by pparβ δ deficiency |
| topic | ATF4 ER stress |
| url | https://hdl.handle.net/10356/83383 http://hdl.handle.net/10220/41419 |
| work_keys_str_mv | AT zareimohammad hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT barrosoemma hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT leivarosana hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT barniolxicotamarta hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT pujoleugenia hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT escolanocarmen hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT vazquezsantiago hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT palomerxavier hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT pardovirginia hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT gonzalezrodriguezagueda hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT valverdeangelam hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT quesadalopeztania hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT villarroyafrancesc hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT wahliwalter hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency AT vazquezcarreramanuel hemeregulatedeif2akinasemodulateshepaticfgf21andisactivatedbypparbddeficiency |